期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | TUMOR BIOLOGY (According to the latest JCR data, this journal is not indexed in the JCR.) LetPub Score 4.0
50 ratings
Rate
Reputation 3.7 Influence 3.1 Speed 9.1 | ||||||||||||||||
期刊簡稱 | TUMOR BIOL | ||||||||||||||||
ISSN | 1010-4283 | ||||||||||||||||
E-ISSN | 1423-0380 | ||||||||||||||||
h-index | 70 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | N.A.自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | https://www.springer.com/journal/13277 | ||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/TUBI | ||||||||||||||||
開放訪問 | Yes | ||||||||||||||||
出版商 | Springer Netherlands | ||||||||||||||||
主題領域 | 医学 | ||||||||||||||||
出版國/地區 | SWITZERLAND | ||||||||||||||||
發行頻率 | 隔月刊行 | ||||||||||||||||
創刊年 | 2010 | ||||||||||||||||
每年文章數 | 1625每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 0.00% | ||||||||||||||||
OA Related Info | APC: Yes( USD2000; ) APC waiver:Check Notes Other charges: No Keywords: molecular biomarkers、tumour markers、tumour targetting Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q0 N/A | ||||||||||||||||
索引 (SCI or SCIE) | |||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1010-4283%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: About 1.0 month(s) | ||||||||||||||||
競爭力 * | 來自作者的數據: About 27.5% | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 | |
[TUMOR BIOLOGY] 的評論 | 撰寫評論 |
作者: 维尔娜菲茨杰拉德 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 15:18:28 評論於 The principle of writing methods is to provide enough experimental information for peers to replicate the experimental process. The indicators and procedures required for the experiment should be described in a comprehensive and standardized manner(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 11:18:57 評論於 Briefly describe the method, with references attached(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 平原文波 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 21:21:00 評論於 How detailed should the method be?(0) 讚! | 平原文波 |
作者: Oswald Edie 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 09:17:19 評論於 How much can methods be abbreviated?(0) 讚! | Oswald Edie |
作者: 太玄傲阳 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-11-07 16:52:15 評論於 Is this still SCI? How can it still be listed as 2nd Tier of Chinese Academy of Sciences?(0) 讚! | 太玄傲阳 |
作者: 南川慕夏 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-07-28 13:37:48 評論於 I have never won(0) 讚! | 南川慕夏 |
作者: 妙春可爱吗 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-06-18 18:59:52 評論於 I have also tried my luck, but I wasn't able to win(0) 讚! | 妙春可爱吗 |
作者: 八荒竹萱 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-01-05 18:49:14 評論於 Please translate the following passage into English and Japanese, and title them ":" and ":"(0) 讚! | 八荒竹萱 |
作者: 玄虚士恩 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-11-01 09:48:44 評論於 Very good(0) 讚! | 玄虚士恩 |
作者: 留云骊美 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-10-08 23:46:59 評論於 Very good(0) 讚! | 留云骊美 |
作者: 天际凝莲 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-09-26 08:06:00 評論於 Can't come back anymore(0) 讚! | 天际凝莲 |
作者: 极乐红雪 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-09-17 19:56:11 評論於 It's good enough to be able to send(0) 讚! | 极乐红雪 |
作者: 极乐红雪 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-09-13 12:05:01 評論於 What are you talking about?(0) 讚! | 极乐红雪 |
作者: 天际香波 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-07-05 13:13:26 評論於 Review speed: 6.0 | Submission acceptance rate: 75.0 Research focus: Medical comprehensive journal Experience sharing: Why does the rejected journal still exist?(0) 讚! | 天际香波 |
作者: Isabel Ramsden 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-06-23 20:10:31 評論於 Please translate the following passage into English and Japanese, with the headings ":" and ":" respectively(0) 讚! | Isabel Ramsden |
作者: Judy Saxton 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-11-14 15:18:14 評論於 Just wait slowly(0) 讚! | Judy Saxton |
作者: Oliver Jerry 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-10-25 10:02:37 評論於 Three months(0) 讚! | Oliver Jerry |
作者: 销魂怡冉 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-10-09 17:33:39 評論於 Can't come back. When will the Shenkan return?(0) 讚! | 销魂怡冉 |
作者: 八荒庆彦 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-08-12 21:27:16 評論於 When will the God publication be back?(0) 讚! | 八荒庆彦 |
作者: 北风成娟 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-08-10 17:28:16 評論於 Thank you for the reminder. It has already been removed from SCI. Please do not submit anymore(0) 讚! | 北风成娟 |
作者: 中原宇荫 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-07-28 21:26:53 評論於 It would be great if it could be published! Muddy research to get promoted 2018-05-06 03:05:00 Published: When I was an undergraduate, I thought a certain professor was very powerful. After studying for a master's degree, I saw many articles on tumor biology, and then I realized that it was so superficial. It's obvious that he's just fooling around. Studying for a master's degree helps people understand many things(0) 讚! | 中原宇荫 |
作者: 阿尔杰伯莎 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-05-06 16:32:41 評論於 I used to think that a certain professor was very powerful when I was an undergraduate. After starting my postgraduate studies, I realized how shallow his articles on tumour biology were. It was obvious that he was just bluffing. Postgraduate studies help people understand many things(0) 讚! | 阿尔杰伯莎 |
作者: 矢泽锐阵 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-04-06 13:49:43 評論於 SCI has been excluded. Don't submit anymore!(0) 讚! | 矢泽锐阵 |
作者: Cara Wat 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-01-15 23:52:55 評論於 Be cautious about submitting. The magazine currently has no updates(0) 讚! | Cara Wat |
作者: Cara Wat 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-01-15 16:41:37 評論於 Please be cautious when investing in some unreliable magazines. It's better to invest in domestic core ones(0) 讚! | Cara Wat |
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 |
Contact us